Regulatory and compounding status All four compounds share a broadly similar regulatory landscape in the United States as of 2026: None are FDA-approved as finished drug products for therapeutic use All are classified as WADA S2 prohibited substances year-round All four have 503A compounding status of Under Review, meaning the FDA Pharmacy Compounding Advisory Committee (PCAC) has nominated them for evaluation but final category assignments (Category 1 permitted for compounding
All participants will undergo volumetric magnetic resonance imaging (MRI) scans, and a subset of the study population will undergo biomarker testing, including amyloid PET, tau PET, and CSF testing
Sockalingam stressed that, as treatments become more accessible, other supports must be strengthened in concert, noting that risks associated with obesity medications include eating disorders and mental-health problems.
Vitamin E is a fat-soluble antioxidant that is vital in the maintenance of healthy-looking skin
An independent prescriber is permitted to prescribe Ozempic for weight loss, as long as they feel it is clinically appropriate and justified
Patients often describe eating less because they genuinely forget about food rather than fighting constant cravings
